Revisions for RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma has only one revision